You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leuprolide oral tablets

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometriosis Trial in Quebec City (Leuprolide Oral Tablet 4-mg QD, Leuprolide Oral Tablet 4-mg BID, Leuprolide Depot)

Completed
Has Results
  • Endometriosis
  • Leuprolide Oral Tablet 4-mg QD
  • +3 more
  • Quebec City, Quebec, Canada
    inVentiv Health Clinique, Inc.
Jan 20, 2022

Endometriosis Trial in United States (Leuprolide Oral Tablet - 120 mg - QD- Treatment A, Leuprolide Oral Tablet - 80 mg - QD -

Recruiting
  • Endometriosis
  • Leuprolide Oral Tablet - 120 mg - QD- Treatment A
  • +4 more
  • Sarasota, Florida
  • +3 more
Mar 21, 2022

Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))

Recruiting
  • Endometriosis Ovary
  • Semarang, Central Java, Indonesia
    Kariadi Hospital
Nov 22, 2023

Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)

Withdrawn
  • Crohn's Disease
  • Oral Ulcer
  • Mesalazine Sustained-Release Tablets
  • Riboflavin Sodium Phosphate Injection
  • Xi'an, Shaanxi, China
    Xijing Hospital
Jan 30, 2023

Surgical Site Infections Trial in Shibin Al Kawm (Ciprodiazole, Ciprofloxacin Tablets & Metronidazole tablets)

Recruiting
  • Surgical Site Infections
  • Shibīn Al Kawm, Menofia, Egypt
    Faculty of Medicine - Menofia University
May 8, 2023

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Relative Bioavailability Trial (PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg)

Not yet recruiting
  • Relative Bioavailability
  • PanCytoVir™ 100 mg/mL oral suspension
  • Probenecid 500 mg
  • (no location specified)
Sep 5, 2023

Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg

Not yet recruiting
  • Healthy Participants
  • Treatment A: Emraclidine 30mg IR tablets (reference)
  • +3 more
  • Overland Park, Kansas
    Overland Park, Kansas
Jun 28, 2023

Graft-versus-host Disease Trial in Beijing (SHR0302)

Not yet recruiting
  • Graft-versus-host Disease
  • Beijing, Beijing, China
    Beijing Hospital
May 4, 2023

Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract, Symptomatic Treatment of Gastric and Duodenal Ulcers Trial in

Not yet recruiting
  • Heartburn
  • +2 more
  • Moscow, Russian Federation
  • +1 more
Oct 19, 2023

Healthy Trial (K-001, K-877-ER, CSG452)

Not yet recruiting
  • Healthy
  • (no location specified)
Feb 1, 2023

Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
  • Tunis, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023

Psoriasis and Psoriatic Arthritis Trial in Ahmedabad (Apremilast 30 mg Tablets, Otezla 30 mg film-coated tablets)

Completed
  • Psoriasis and Psoriatic Arthritis
  • Apremilast 30 mg Tablets
  • Otezla 30 mg film-coated tablets
  • Ahmedabad, Gujarat, India
    Lambda Therapeutic Research Ltd.
Oct 18, 2023

Bronchiectasis Trial (Staphylococcus and Neisseria Tablets, On-demand treatment)

Recruiting
  • Bronchiectasis
  • Staphylococcus and Neisseria Tablets
  • On-demand treatment
  • Jinan, Shandong, China
    Department of Respiratory, The First Affiliated Hospital of Shan
Sep 22, 2022

MDD (MDD) Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets, Vortioxetine Hydrobromide Tablets)

Active, not recruiting
  • Major Depressive Disorder (MDD)
  • Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
  • Vortioxetine Hydrobromide Tablets
  • Ahmedabad, Gujarat, India
    Cliantha Research Limited
Nov 3, 2022

Chronic HBV Infection Trial in Chongqing (PA3670)

Recruiting
  • Chronic HBV Infection
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital of Chongqing Medical University
May 6, 2023

Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)

Recruiting
  • Imumune Thrombocytopenia(ITP) Human Mass Balance
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 12, 2023

Hypoparathyroidism Trial in Jerusalem (EBP05, Forteo 20 mg, EBP11)

Recruiting
  • Hypoparathyroidism
  • Jerusalem, Israel
    Clinical Research Center Hadassah Ein Kerem Medical Center
Jul 27, 2023

Fed Conditions Trial in Bab Souika (Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg), Galvumet® Film Coated Tablets

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
  • Galvumet® Film Coated Tablets (850 mg / 50 mg)
  • Bab Souika, Tunise, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 22, 2023

Healthy Trial in Randwick (Hemay005 60 mg)

Not yet recruiting
  • Healthy
  • Hemay005 60 mg
  • Randwick, New South Wales, Australia
    Scientia Clinical Research Ltd
Jul 3, 2023

Mantle Cell Lymphoma Trial in Hangzhou (LP-168 tablet)

Recruiting
  • Mantle Cell Lymphoma
  • LP-168 tablet
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jun 24, 2023

Hypertension Trial in Guangdong (Amlodipine besylate tablets (trade name: Norfloxacin ®), Amlodipine besylate controlled-release

Not yet recruiting
  • Hypertension
  • Amlodipine besylate tablets (trade name: Norfloxacin ®）
  • Amlodipine besylate controlled-release tablets
  • Guangdong, Guangzhou, China
    Zhujiang Hospital of Southern Medical University
Jan 3, 2023

Breast Cancer Trial in Lexington, East Syracuse (TOL2506, Tamoxifen, Letrozole tablets)

Enrolling by invitation
  • Breast Cancer
  • Lexington, Kentucky
  • +1 more
Jan 9, 2023

Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin

Not yet recruiting
  • Pain
  • Insomnia
  • Compound ibuprofen polyrelease tablets
  • reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Feb 6, 2023

Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg

Active, not recruiting
  • Hypertension
  • Coronary Artery Disease
  • Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
  • Norvasc 5 mg tablets of Pfizer Labs
  • Vadodara, Gujarat, India
    Accutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023